Sell Alert: 10 High-Profile Stocks Just Dumped by Top Analysts

8. Five9 (NASDAQ:FIVN)

Market Cap: $2.12 billion

Average Upside Potential: 26%

Number of Hedge Fund Holders: 35

Evercore ISI cut Five9 to In Line from Outperform on November 6 and kept its price target at $24. The firm said a clear turning point in growth is not yet visible and that near-term positive catalysts are missing.

The quarter had real strength. Revenue rose 13% to $323.3 million in the third quarter, and subscription revenue grew 16%. AI revenue was roughly $45 million, up 91% from a year earlier, and management raised its full-year AI growth outlook to at least 75% from at least 60%.

The profit outlook was the weak spot. Fourth-quarter non-GAAP earnings per share guidance of $0.88 to $0.92 came in below estimates, and full-year guidance of $3.17 to $3.21 implies a lower midpoint than the $3.26 cited in prior quarters. GAAP gross margin slipped to 53.4% from 55.0% a year earlier, and the company reaffirmed rather than raised its EBITDA margin and free-cash-flow targets.

Five9 also has a pending acquisition of Level AI, which it expects to close in the fourth quarter. Its guidance excludes that deal, and management said it “bought it for a steal.”

7. International Flavors & Fragrances (NYSE:IFF)

Market Cap: $20.69 billion

Average Upside Potential: 19%

Number of Hedge Fund Holders: 39

BofA cut International Flavors & Fragrances to Underperform from Buy on November 6 and lowered its price target to $91 from $95. The bank said the shares had risen substantially and lack near-term catalysts, making further upside hard to achieve, and it pointed to softness in businesses outside Taste. BofA also expects raw material inflation of about 3% to limit operating leverage into the first half of 2027. It called the third quarter strong but said the risk/reward has shifted as margin pressure builds.

The report itself had plenty of growth in it. Third-quarter net sales were $1.94 billion, up 4%, and adjusted operating EBITDA of $403 million beat BofA’s own estimate of $398 million. Health & Biosciences grew by only 1%, the slowest of the company’s three segments. IFF also raised the low end of its 2026 sales outlook, which is now $7.5 billion to $7.6 billion.

The company is reshaping its portfolio too. The sale of its Food Ingredients business is on track to close by the end of the second quarter of 2027, and IFF has finished its share repurchase authorization, which it had set at $500 million.

6. Gartner (NYSE:IT)

Market Cap: $11.99 billion

Average Upside Potential: 6%

Number of Hedge Fund Holders: 50

Barclays analyst Manav Patnaik cut Gartner to Underweight from Equal Weight on November 6 but raised the price target to $185 from $150. He said contract value growth is slowing and exiting the year at a low-single-digit rate, and that the company’s per-seat exposure is “already too high for a world in which the macro pressures are likely to continue.” Barclays also remains concerned about AI disruption to information services companies, even after Gartner’s shares rallied 27% from early October to early November, and concluded that “Gartner’s setup into next year is unattractive.”

Gartner’s own report gave the bulls something to point to. Adjusted earnings per share rose 30.1% to $3.59, and the company raised its full-year guidance for revenues, adjusted EBITDA excluding the divested operation, adjusted EPS and free cash flow.

Total contract value reached $5.3 billion, up 2.5% from a year earlier, with both Global Technology Sales and Global Business Sales growing their contract value. Quarterly revenue of $1.51 billion slipped 1.3% as reported. The shares had fallen 13.2% on the Tuesday after the report, before the downgrade arrived.

5. Molson Coors Beverage (NYSE:TAP)

Market Cap: $7.54 billion

Average Upside Potential: 4%

Number of Hedge Fund Holders: 41

Wells Fargo analyst Chris Carey cut Molson Coors to Underweight from Equal Weight on November 6 and lowered his price target to $36 from $38. He cited ongoing inflation compressing gross margins and concern about market share erosion, and he sees more than 20% downside risk to consensus earnings estimates. Wells Fargo said the stock’s valuation can “track back to lows,” and it expects 2027 to be challenging.

The company’s third-quarter results showed the same pressure. Net sales were $2.93 billion, down 1.6% and just short of the $2.94 billion analysts expected, while adjusted earnings per share of $1.46 edged past the $1.45 consensus. Global beer brand volume fell 4.9% from a year earlier.

The company then lowered its 2026 outlook. It now expects constant-currency net sales to fall 1% to 2%, compared with a prior range of roughly flat, and underlying earnings per share to fall 16% to 19%, against a prior decline of 11% to 15%. Management cited lower sales volumes and higher costs for materials, logistics and manufacturing, including about $30 million from the Midwest Premium pricing impact.